老年T1肾癌患者手术与观察决策中的竞争性死亡预测
基于监测、流行病学和最终结果-医疗保险数据库的11,192例T1肾癌患者,构建竞争风险回归模型预测手术或观察后的癌症特异性死亡(CSM)与其他原因死亡(OCM)。中位随访64个月时,5年CSM率为6.7%、OCM率为24%。手术与更低的CSM风险(HR 0.46)和OCM风险(HR 0.66)相关;手术相较观察的获益在较年轻、较健康且肿瘤较大的患者中更明显。
要点
- 手术与更低的CSM风险(HR 0.46)及OCM风险(HR 0.66)相关。
- 年龄、CCI和肿瘤大小与更高的CSM风险相关。
- 手术相较观察的获益在较年轻、较健康、肿瘤较大的患者中更明显。
核心结论
- 手术相较观察的获益在较年轻、较健康且肿瘤较大的患者中更明显。
- 所提出的模型可辅助临床决策,提供两种治疗方式后CSM与OCM风险的关键信息。
研究设计与样本
- 研究纳入监测、流行病学和最终结果-医疗保险数据库中11,192例接受手术或观察的T1肾癌患者。
- 拟合竞争风险回归模型预测手术或观察后的CSM与OCM。
- 协变量包括年龄、性别、种族、Charlson合并症指数(CCI)、急性肾损伤或慢性肾脏病病史、肿瘤大小和诊断年份。
主要发现
- 中位随访64个月时,5年CSM率为6.7%,5年OCM率为24%。
- 预测CSM的竞争风险回归中,手术(HR 0.46;P < .0001)和诊断年份(HR 0.96;P < .0001)与更低的CSM风险相关。
- 预测CSM的竞争风险回归中,年龄(HR 1.05;P < .0001)、CCI(HR 1.07;P < .0001)和肿瘤大小(HR 1.03;P < .0001)与更高的CSM风险相关。
- 预测OCM的竞争风险回归中,手术(HR 0.66;P < .0001)、女性(HR 0.83;P < .0001)、其他种族(HR 0.82;P < .0001)和诊断年份(HR 0.95;P < .0001)与更低的OCM风险相关。
- 预测OCM的竞争风险回归中,年龄(HR 1.06;P < .0001)、非洲裔美国人种族(HR 1.16;P < .01)、CCI(HR 1.17;P < .0001)和急性肾损伤或慢性肾脏病(HR 1.35;P < .0001)与更高的OCM风险相关。
临床怎么用
- 作者认为所提出的模型可辅助临床决策,提供手术或观察后CSM与OCM风险的关键信息。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To predict the risk of cancer-specific mortality (CSM) or other-cause mortality (OCM) for T1 kidney cancer patients, aiming at identifying those who would benefit from surgery over observation. PATIENTS AND METHODS: Overall, 11,192 T1 kidney cancer patients treated with surgery or observation in the Surveillance, Epidemiology, and End Results-Medicare database were assessed. A competing risk regression (CRR) model was fitted to predict CSM and OCM after surgery or observation. Covariates consisted of age, gender, race, Charlson comorbidity index (CCI), history of acute kidney injury or chronic kidney disease, tumor size, and year of diagnosis. RESULTS: At a median follow-up of 64 months, the 5-year rates of CSM and OCM were 6.7% and 24%, respectively. At CRR predicting CSM, surgery (hazard ratio [HR] 0.46; P < .0001) and year of diagnosis (HR 0.96; P < .0001) were associated with lower CSM risk. Conversely, age (HR 1.05; P < .0001), CCI (HR 1.07; P < .0001), and tumor size (HR 1.03; P < .0001) were associated with higher CSM risk. At CRR predicting OCM, surgery (HR 0.66; P < .0001), female gender (HR 0.83; P < .0001), Other race (HR 0.82; P < .0001), and year of diagnosis (HR 0.95; P < .0001) were associated with lower OCM risk. Conversely, age (HR 1.06; P < .0001), African American race (HR 1.16; P < .01), CCI (HR 1.17; P < .0001), and acute kidney injury or chronic kidney disease (HR 1.35; P < .0001) were associated with higher OCM risk. CONCLUSION: The benefit of surgery over observation was more pronounced in younger and healthier patients with larger tumors. The proposed model can aid in clinical decision-making, providing crucial information on CSM and OCM risk after either treatment modality.
引用
- Larcher A, Trudeau V, Dell'Oglio P, et al. Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer. Urology. 2016. PMID: 27884597. doi:10.1016/j.urology.2016.08.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。